IGI Laboratories, Inc., a provider of topical formulation development, analytical, manufacturing and packaging services, appointed Michael B. Hemric to the company's board of directors. Mr. Hemric will take the place of Mr. Steven J. Morris, who resigned from the company’s board of directors effective July 1, 2009.

“We are very pleased to have Mike join our board of directors. Mike is a successful executive with extensive knowledge of the generic and branded pharmaceutical market. As we advance our over the counter and prescription product development portfolio and broaden our presence within the specialty pharmaceutical sector, his considerable strategic planning and commercial development experience will be invaluable to IGI. In addition, the Board sincerely thanks Steven for his support and strong contribution to IGI over his tenure as a board member,” said Joyce Erony, chairperson of IGI Laboratories, Inc.

Mr. Hemric, has over 30 years of experience in the consumer health care industry. From February 1981 until his retirement in February 2008, he held various senior management positions at Alcon Laboratories including General Manager of Alcon’s Consumer Product and Pharmaceutical divisions and most recently as President of its Far East division. Mr. Hemric received a B.A. from Wake Forest University and is a graduate of the Harvard Program for Management Development.